Therefore, our finding that GCN2iB decreased the expression of CD36 and other lipid metabolism-related genes suggests a potential mechanism for the GCN2iB-mediated reduction in cardiac TG levels in T2D mice. The gene discussed is CD36; the disease is type 2 diabetes mellitus.